Thu. 8 Aug 2024, 5:06pm ET
Benzinga
Earnings, Earnings Beats, News
Ventyx Biosciences (NASDAQ:VTYX) reported quarterly losses of $(0.45) per share which beat the analyst consensus estimate of $(0.57) by 21.05 percent. This is a 50.55 percent increase over losses of $(0.91) per share from the same period last year.